How antimalarial drug resistance affects post-treatment prophylaxis
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Slowly eliminated antimalarial drugs suppress malaria reinfections for a period of time determined by the dose, the pharmacokinetic properties of the drug, and the susceptibility of the infecting parasites. This effect is called post-treatment prophylaxis (PTP). The clinical benefits of preventing recrudescence (reflecting treatment efficacy) compared with preventing reinfection (reflecting PTP) need further assessment. Antimalarial drug resistance shortens PTP. While blood concentrations are in the terminal elimination phase, the degree of shortening may be estimated from measurements of in-vitro susceptibility and the terminal elimination half-life. More information is needed on PTP following intermittent preventive treatments, and on the relationship between the duration of PTP and immunity, so that policy recommendations can have a firmer evidence base.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
O. ter Kuile, F., van Eijk, A. M., & Filler, S. J. (2007) · JAMA · doi:10.1001/jama.297.23.2603 · Cited by 355
Reducing the burden of malaria in pregnancy by preventive strategies
Menéndez, C., D'Alessandro, U., & ter Kuile, F. O. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70024-5 · Cited by 188 · cited 1×
“Obtaining this information is necessary in order to determine the relationship between PTP and important clinical end-points such as anaemia and birthweight, and thus the effects of resistance [14].”
Background
Cited by
Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria
Eastman, R. T., & Fidock, D. A. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2239 · Cited by 568
Smithuis, F., Kyaw, M. K., Phe, O., Win, T., Aung, P. P., Oo, A. P. P., Naing, A. L., Nyo, M. Y., Myint, N. Z. H., Imwong, M., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70187-0 · Cited by 177
Self-citationthe FSP/MISAME study Group, Valea, I., Tinto, H., Drabo, M. K., Huybregts, L., Sorgho, H., Ouedraogo, J.-B., Guiguemde, R. T., van Geertruyden, J. P., Kolsteren, P., et al. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-71 · Cited by 87
“The length of protection may become shorter and infection may occur progressively earlier as SP resistance increases [16].”
BackgroundCairns, M., Cisse, B., Sokhna, C., Cames, C., Simondon, K., Ba, E. H., Trape, J.-F., Gaye, O., Greenwood, B. M., & Milligan, P. J. M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01161-09 · Cited by 26
Borrmann, S., Peto, T., Snow, R. W., Gutteridge, W., & White, N. J. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050227 · Cited by 15
“The superiority of the post-treatment prophylactic efficacy of a new drug with comparatively higher anti-liver stage activity or prolonged plasma half-life can be best examined in areas with high re-infection rates because of the postulated differential impact on re-infection and/or secondary malaria rates [33].”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- White, N. J.
- Venue
- Malaria Journal
- Published
- 2008-01-11
- Volume
- 7
- Issue
- 1
- Pages
- 9-9
- ISSN
- 1475-2875 (ISSN-L)
- OpenAlex
- W2116510803
- Cited by
- 82
- References
- 2
- FWCI
- 11.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.